These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7585731)

  • 41. Oestradiol and epidermal growth factor in breast cyst fluid.
    Lai LC; Dunkley SA; Reed MJ; Ghilchik MW; James VH
    Anticancer Res; 1989; 9(6):1853-6. PubMed ID: 2627131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Steroids excreted by human skin. II. C19-steroid sulphates in human axillary sweat.
    Tóth I; Faredin I
    Acta Med Hung; 1985; 42(1-2):21-8. PubMed ID: 3162156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human gross cyst breast disease and cystic fluid: bio-molecular, morphological, and clinical studies.
    Mannello F; Tonti GA; Papa S
    Breast Cancer Res Treat; 2006 May; 97(2):115-29. PubMed ID: 16331347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dehydroepiandrosterone, androgens and the mammary gland.
    Labrie F
    Gynecol Endocrinol; 2006 Mar; 22(3):118-30. PubMed ID: 16835073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Latent forms of transforming growth factor-beta 2 (TGF-beta 2) in breast cyst fluid.
    Erbas H; Lennard TW; Lai LC
    Anticancer Res; 1999; 19(4B):3077-82. PubMed ID: 10652596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationships between androgen and estrogen sulfates in breast cyst fluid.
    Nahoul K; Kottler ML
    Clin Chim Acta; 1992 Aug; 209(3):179-87. PubMed ID: 1395048
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Steroid biochemistry and categorization of breast cyst fluid: relation to breast cancer risk.
    Angeli A; Dogliotti L; Naldoni C; Orlandi F; Puligheddu B; Caraci P; Bucchi L; Torta M; Bruzzi P
    J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):333-9. PubMed ID: 8043497
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma adrenal androgens and risk of breast cancer in premenopausal women.
    Page JH; Colditz GA; Rifai N; Barbieri RL; Willett WC; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1032-6. PubMed ID: 15184260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characteristics of cystic breast disease with special regard to breast cancer development.
    Budai B; Számel I; Sulyok Z; Német M; Bak M; Ottó S; Reed MJ; Purohit A; Parish DC; Kralovánszky J
    Anticancer Res; 2001; 21(1B):749-52. PubMed ID: 11299838
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Absence of correlation between the concentrations of carcinoembryonic antigen (CEA) and the tumor growth factor beta 2 (TGFB2) in the two main types of breast macrocysts].
    Ruibal A; Núñez MI; Schneider J; del Río Mf; Delgado S; Rabadán F; Tejerina A
    Rev Esp Med Nucl; 1999; 18(2):88-93. PubMed ID: 10352320
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Steroid patterns of benign breast disease.
    Castagnetta L; Granata OM; Brignone G; Blasi L; Arcuri F; Mesiti M; D'Aquino A; Preitano W
    Ann N Y Acad Sci; 1990; 586():121-36. PubMed ID: 2141455
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sources of elevated serum androgens in postmenopausal women who develop breast cancer.
    Dorgan JF; Boudou P; Stanczyk FZ; Longcope C; Tejpar AA; Falk RT; Schussler N; Stephenson HE
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):407-10. PubMed ID: 11319184
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between the concentrations of estriol sulfate and estrone sulfate in human breast cyst fluid.
    Levitz M; Raju U; Arcuri F; Brind JL; Vogelman JH; Orentreich N; Granata OM; Castagnetta L
    J Clin Endocrinol Metab; 1992 Sep; 75(3):726-9. PubMed ID: 1387652
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
    Tworoger SS; Missmer SA; Eliassen AH; Spiegelman D; Folkerd E; Dowsett M; Barbieri RL; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Accumulation of 4- and 5-ene steroid sulfates in human breast cyst fluids.
    Maeda Y; Tanaka E; Fujiwara M; Watanabe R; Furusawa H; Matsu T; Nakahara H; Nanba K; Higashi S; Setoguchi T
    J Steroid Biochem Mol Biol; 2002 Jul; 81(3):249-53. PubMed ID: 12163136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The concentration of 16x-hydroxy androgens in serum and cyst fluid of women with gross cystic disease of the breast.
    Raju U; Bradlow HL; Skidmore FD; Levitz M
    Steroids; 1989 Jul; 54(1):101-12. PubMed ID: 2530661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transforming growth factor beta 2 (TGF beta 2) and dehydroepiandrosterone sulphate (DHEAs) levels in breast macrocyst fluids. Different behaviour according to cyst type.
    Ruibal A; Nuñez MI; Schneider J; Del Rio MC; Rabadan F; Tejerina A
    Int J Biol Markers; 1998; 13(3):173-5. PubMed ID: 10079395
    [No Abstract]   [Full Text] [Related]  

  • 58. Estriol-3-sulfate in human breast cyst fluid. Concentrations, possible origin, and physiologic implications.
    Raju U; Bradlow HL; Levitz M
    Ann N Y Acad Sci; 1990; 586():83-7. PubMed ID: 2141460
    [No Abstract]   [Full Text] [Related]  

  • 59. Cations and dehydroepiandrosterone-sulfate in cyst fluid of pre- and menopausal patients with gross cystic disease of the breast. Evidence for the existence of subpopulations of cysts.
    Dogliotti L; Orlandi F; Torta M; Buzzi G; Naldoni C; Mazzotti A; Angeli A
    Eur J Cancer Clin Oncol; 1986 Nov; 22(11):1301-7. PubMed ID: 2951257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of spontaneous breast cancer formation in female C3H(Avy/a) mice by long-term treatment with dehydroepiandrosterone.
    Schwartz AG
    Cancer Res; 1979 Mar; 39(3):1129-32. PubMed ID: 154968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.